2-(2-phenylpyrrolidin-1-yl)pyridine-3-carboxylic acid, 95.0%, 1g

5-Bromo-2-chloro(trifluoromethoxy)benzene, 97.0%, 1g

Ethyl (R)-3-Piperidinecarboxylate L-Tartrate>98.0%(T)25g

1-(3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine, 97%, 5g

5-Bromo-3-chloro-2-fluorophenol, 95.0%, 1g

Fmoc-D-Cit-OH, 98%, 5g

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanol, 95.0%, 10g

4-(o-Tolyl)-1,2,3,6-tetrahydropyridine hydrochloride, 98%, 1g

Methyl(3S)-1-[(2,4-dimethoxyphenyl)methyl]-5-oxo-pyrrolidine-3-carboxylate, 98%, 250mg

2-Tert-butyl-4-[(4-chlorophenyl)methylidene]-1,2,3,4-tetrahydroacridine-9-carboxylic acid, 95%, 250mg

Anti-Sialyl Lewis X Monoclonal Antibody1vial

4-Bromo-5-methylpyrazolo[1,5-a]pyridine, 95.0%, 50mg

3,3'-Dichlorobenzhydrol, 97.0%, 5g